| Bacillus anthracis |
Anthrax lethal factor |
Potency |
10000.0 |
nM |
None |
| Bacillus anthracis |
Anthrax lethal factor |
Potency |
25118.9 |
nM |
None |
| Bacillus subtilis |
4'-phosphopantetheinyl transferase ffp |
Potency |
25118.9 |
nM |
None |
| Bacillus subtilis |
4'-phosphopantetheinyl transferase ffp |
Potency |
63095.7 |
nM |
None |
| Bos taurus |
Calmodulin |
Kd |
3400.0 |
nM |
10.1016/j.ejmech.2016.03.045 |
| Bos taurus |
Calmodulin |
Kd |
5000.0 |
nM |
10.1016/j.ejmech.2016.03.045 |
| Bos taurus |
Progesterone receptor |
IC50 |
nan |
None |
None |
| Bos taurus |
Progesterone receptor |
Ki |
nan |
None |
None |
| Bos taurus |
Serum albumin |
log K |
3.8 |
None |
10.1021/jm00213a022 |
| Bos taurus |
Serum albumin |
logKd |
4.67 |
None |
10.1021/jm00213a022 |
| Cavia porcellus |
Leukotriene C4 synthase |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
Ki |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Ki |
nan |
None |
None |
| Chlorocebus sabaeus |
Vero C1008 |
CC50 |
7940.0 |
nM |
10.6019/CHEMBL4651402 |
| Chlorocebus sabaeus |
Vero C1008 |
pCC50 |
5.1 |
None |
10.6019/CHEMBL4651402 |
| Cryptosporidium parvum |
Cryptosporidium parvum |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Entamoeba histolytica |
Entamoeba histolytica |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Hepatitis C virus |
NS3 |
IC50 |
700.0 |
nM |
10.1021/jm0400101 |
| Homo sapiens |
3-beta-hydroxysteroid-delta(8),delta(7)-isomerase |
Ki |
8.0 |
nM |
10.1021/jm049073+ |
| Homo sapiens |
78 kDa glucose-regulated protein |
Potency |
52119.4 |
nM |
None |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Acetylcholinesterase |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30100.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
54.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
2100.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
3229.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
15000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
979.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
2000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Androgen Receptor |
Inhibition |
2.8 |
% |
10.1073/pnas.0609752104 |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Arachidonate 15-lipoxygenase |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
Arachidonate 15-lipoxygenase, type II |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
17782.8 |
nM |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
16353.5 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
20587.8 |
nM |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-3 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-glucocerebrosidase |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Bile salt export pump |
AC50 |
185741.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
IC50 |
10000.0 |
nM |
10.1002/hep.27206 |
| Homo sapiens |
Bile salt export pump |
IC50 |
10000.0 |
nM |
10.1124/dmd.112.047068 |
| Homo sapiens |
Bradykinin B1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Bradykinin B2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Brain |
Drug uptake |
4.0 |
ug ml-1 |
10.1007/s00044-009-9287-4 |
| Homo sapiens |
Caco-2 |
IC10 |
11.3 |
uM |
10.1016/j.bmc.2007.01.024 |
| Homo sapiens |
Calcitonin receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Calmodulin |
Kd |
1000.0 |
nM |
10.1021/jm701406e |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
IC50 |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cellular tumor antigen p53 |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Cellular tumor antigen p53 |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Chromobox protein homolog 1 |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Chromobox protein homolog 1 |
Potency |
79432.8 |
nM |
None |
| Homo sapiens |
Corticotropin releasing factor receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Corticotropin releasing factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
630.96 |
nM |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
1000.0 |
nM |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
7943.28 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
12589.25 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Potency |
1995.3 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
1000.0 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
1995.26 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Potency |
316.2 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Potency |
1000.0 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Potency |
1995.3 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
10000.0 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
15848.93 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
DNA dC->dU-editing enzyme APOBEC-3G |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
DNA-dependent protein kinase |
IC50 |
100000.0 |
nM |
10.1016/j.bmcl.2012.06.053 |
| Homo sapiens |
DNA polymerase kappa |
Potency |
18887.6 |
nM |
None |
| Homo sapiens |
DNA repair protein RAD52 homolog |
AC50 |
13000.0 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
129.3 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
450.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
Activity |
96.0 |
% |
10.1016/j.bmcl.2007.03.064 |
| Homo sapiens |
Dopamine D1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Inhibition |
95.0 |
% |
10.1016/j.bmc.2015.07.007 |
| Homo sapiens |
Dopamine D1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Potency |
129.9 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
Potency |
891.3 |
nM |
None |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
14.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
Activity |
100.0 |
% |
10.1016/j.bmcl.2007.03.064 |
| Homo sapiens |
Dopamine D2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
Inhibition |
95.0 |
% |
10.1016/j.bmc.2015.07.007 |
| Homo sapiens |
Dopamine D2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
20.3 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
Activity |
99.0 |
% |
10.1016/j.bmcl.2007.03.064 |
| Homo sapiens |
Dopamine D3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
Inhibition |
95.0 |
% |
10.1016/j.bmc.2015.07.007 |
| Homo sapiens |
Dopamine D3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
Inhibition |
73.0 |
% |
10.1016/j.bmc.2015.07.007 |
| Homo sapiens |
Dopamine D4 receptor |
Inhibition |
95.0 |
% |
10.1016/j.bmc.2015.07.007 |
| Homo sapiens |
Dopamine D4 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D5 receptor |
Inhibition |
81.0 |
% |
10.1016/j.bmc.2015.07.007 |
| Homo sapiens |
Dopamine D5 receptor |
Inhibition |
95.0 |
% |
10.1016/j.bmc.2015.07.007 |
| Homo sapiens |
Dopamine transporter |
AC50 |
12553.3 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Emopamil-binding protein-like |
Ki |
3.9 |
nM |
10.1016/j.bmc.2012.10.038 |
| Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
199.5 |
nM |
None |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
Ki |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-B |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
3490.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor beta |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
Ki |
nan |
None |
None |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gastric inhibitory polypeptide receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Geminin |
Potency |
23109.3 |
nM |
None |
| Homo sapiens |
Geminin |
Potency |
26608.6 |
nM |
None |
| Homo sapiens |
Geminin |
Potency |
29092.9 |
nM |
None |
| Homo sapiens |
Ghrelin receptor |
AC50 |
23462.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucagon-like peptide 1 receptor |
Potency |
8912.5 |
nM |
None |
| Homo sapiens |
Glucagon receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Glutathione reductase |
IC50 |
nan |
nM |
10.1021/jm960814j |
| Homo sapiens |
Glycoprotein hormones alpha chain |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
Guanine nucleotide-binding protein G(s), subunit alpha |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
H4 |
Activity |
76.62 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
94.28 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
105.6 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
105.72 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
109.0 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
111.52 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
124.78 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
136.58 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
364.24 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
520.24 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
1010.35 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
nan |
None |
10.1073/pnas.0709695104 |
| Homo sapiens |
HEK293 |
Potency |
1258.9 |
nM |
None |
| Homo sapiens |
HEK293 |
Potency |
7304.8 |
nM |
None |
| Homo sapiens |
HepG2 |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
HERG |
AC50 |
749.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
IC50 |
6226.0 |
nM |
None |
| Homo sapiens |
HERG |
Ki |
5100.8 |
nM |
None |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
112.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
1897.4 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
470.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
10507.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone acetyltransferase GCN5 |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-3.6 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
59.55 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
26679.5 |
nM |
None |
| Homo sapiens |
HMG-CoA reductase |
IC50 |
nan |
None |
None |
| Homo sapiens |
HMG-CoA reductase |
Ki |
nan |
None |
None |
| Homo sapiens |
Homo sapiens |
Activity |
nan |
None |
10.1002/hep.27206 |
| Homo sapiens |
Homo sapiens |
Cmax |
5.3 |
nM |
10.1002/hep.27206 |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
2.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
Fabs |
16.0 |
% |
10.1124/dmd.110.034629 |
| Homo sapiens |
Homo sapiens |
IC50 |
201800.0 |
nM |
10.1021/jm00094a004 |
| Homo sapiens |
Interleukin-8 receptor A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor A |
Ki |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
Ki |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
5924.5 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Kappa opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
KG-1a |
IC50 |
4580.0 |
nM |
10.1016/j.ejmech.2019.111692 |
| Homo sapiens |
Leukocyte common antigen |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
Ki |
nan |
None |
None |
| Homo sapiens |
Lysine-specific demethylase 4A |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
MAP kinase ERK1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
MAP kinase p38 alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
Ki |
nan |
None |
None |
| Homo sapiens |
MCF7 |
IC50 |
11330.0 |
nM |
10.1016/j.ejmech.2019.111692 |
| Homo sapiens |
MCF7 |
Inhibition |
63.8 |
% |
10.1016/j.ejmech.2019.111692 |
| Homo sapiens |
MCF7-DOX |
MDR ratio |
3.4 |
None |
10.1021/jm970786k |
| Homo sapiens |
MDA-MB-231 |
IC50 |
21580.0 |
nM |
10.1016/j.ejmech.2019.111692 |
| Homo sapiens |
MDA-MB-231 |
Inhibition |
nan |
% |
10.1016/j.ejmech.2019.111692 |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
11906.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
8953.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
1258.9 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
Ki |
nan |
None |
None |
| Homo sapiens |
Mothers against decapentaplegic homolog 3 |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Motilin receptor |
AC50 |
8100.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
M-phase phosphoprotein 8 |
Potency |
37685.8 |
nM |
None |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Mu opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
8900.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
7799.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
Ki |
nan |
None |
None |
| Homo sapiens |
NADPH oxidase 1 |
IC50 |
17000.0 |
nM |
None |
| Homo sapiens |
NCI-H1650 |
Activity |
nan |
None |
10.1016/j.bmc.2015.07.007 |
| Homo sapiens |
NCI-H1650 |
GI50 |
12200.0 |
nM |
10.1016/j.bmc.2015.07.007 |
| Homo sapiens |
NEDD8/Cullin-1 |
Inhibition |
nan |
% |
10.1016/j.ejmech.2019.111848 |
| Homo sapiens |
Neurokinin 1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
19600.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurotensin receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Niemann-Pick C1 protein |
Potency |
58047.9 |
nM |
None |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
9610.7 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
20596.2 |
nM |
None |
| Homo sapiens |
Nuclear factor NF-kappa-B p105 subunit |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
6300.0 |
nM |
10.1006/bbrc.2001.6000 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
7200.0 |
nM |
10.1006/bbrc.2001.6000 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
10900.0 |
nM |
10.1006/bbrc.2001.6000 |
| Homo sapiens |
P-glycoprotein 1 |
Ki |
6500.0 |
nM |
10.1021/jm020941h |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
15000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 5A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 5A |
Ki |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Prelamin-A/C |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Protein kinase C alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Protein kinase C alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Ras-related protein Rab-9A |
Potency |
58047.9 |
nM |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Regulator of G-protein signaling 4 |
Potency |
18887.6 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase AKT |
Inhibition |
nan |
% |
10.1016/j.bmc.2015.07.007 |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
Activity |
nan |
None |
10.1073/pnas.0709695104 |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
Potency |
14689.2 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
Potency |
16481.6 |
nM |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
7000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
18926.5 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
Activity |
76.0 |
% |
10.1016/j.bmcl.2007.03.064 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
16.5 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
774.6 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
Activity |
99.0 |
% |
10.1016/j.bmcl.2007.03.064 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
84.4 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
1846.7 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
1483.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Activity |
91.0 |
% |
10.1016/j.bmcl.2007.03.064 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
17000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
AC50 |
4278.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
SH-SY5Y |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Sigma opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
Ki |
15.0 |
nM |
10.1021/jm049073+ |
| Homo sapiens |
Sigma opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
SK-BR-3 |
IC50 |
15890.0 |
nM |
10.1016/j.ejmech.2019.111692 |
| Homo sapiens |
Sodium channel alpha subunits; brain (Types I, II, III) |
IC50 |
5000.0 |
nM |
10.1021/jm00381a019 |
| Homo sapiens |
Sodium channel alpha subunits; brain (Types I, II, III) |
Inhibition |
79.8 |
% |
10.1021/jm00381a019 |
| Homo sapiens |
SUM-159-PT |
Activity |
12.0 |
None |
10.1016/j.ejmech.2019.111692 |
| Homo sapiens |
SUM-159-PT |
IC50 |
17030.0 |
nM |
10.1016/j.ejmech.2019.111692 |
| Homo sapiens |
Survival motor neuron protein |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Thrombopoietin |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane-A synthase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Thromboxane-A synthase |
Ki |
nan |
None |
None |
| Homo sapiens |
Thyroid stimulating hormone receptor |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosine-protein kinase FYN |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
3719.2 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
4610.9 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
5173.5 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
6613.8 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
16360.1 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
20596.2 |
nM |
None |
| Homo sapiens |
U-87 MG |
EC50 |
13500.0 |
nM |
10.1016/j.ejmech.2018.03.055 |
| Homo sapiens |
U-87 MG |
Efficacy |
79.0 |
% |
10.1016/j.ejmech.2018.03.055 |
| Homo sapiens |
U-87 MG |
Efficacy |
82.0 |
% |
10.1016/j.ejmech.2018.03.055 |
| Homo sapiens |
U-87 MG |
IC50 |
9900.0 |
nM |
10.1016/j.ejmech.2018.03.055 |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
52673.2 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
56234.1 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48 |
IC50 |
8000.0 |
nM |
10.1021/acs.jmedchem.6b00596 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-3 |
Activity |
0.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 1A4 |
Activity |
165.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 1A4 |
Activity |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
18289.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vitamin D receptor |
Potency |
56234.1 |
nM |
None |
| Issatchenkia orientalis |
ATP binding cassette transporter Abc1p |
Activity |
nan |
None |
10.1128/aac.01095-08 |
| Leishmania amazonensis |
Leishmania amazonensis |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Leishmania donovani |
Leishmania donovani |
IC50 |
7360.0 |
nM |
10.6019/CHEMBL3392926 |
| Leishmania donovani |
Leishmania donovani |
IC50 |
52930.0 |
nM |
10.6019/CHEMBL3392926 |
| Leishmania donovani |
Leishmania donovani |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Leishmania infantum |
Leishmania infantum |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Leishmania major |
Leishmania major |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Leishmania mexicana |
Leishmania mexicana |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Mus musculus |
Delta(24)-sterol reductase |
Inhibition |
nan |
% |
10.1021/acs.jmedchem.5b01696 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1016/j.bmc.2015.07.007 |
| Mus musculus |
Nitric oxide synthase, inducible |
IC50 |
nan |
None |
None |
| Mus musculus |
Nitric oxide synthase, inducible |
Ki |
nan |
None |
None |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
IC50 |
8.0 |
ug.mL-1 |
10.1016/j.bmc.2014.07.050 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
5.0 |
ug.mL-1 |
10.1016/j.bmc.2023.117212 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
7.6 |
ug.mL-1 |
10.1016/j.bmcl.2007.03.064 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
IC50 |
3150.0 |
nM |
10.1128/aac.00803-09 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
IC50 |
12260.0 |
nM |
10.1128/aac.00803-09 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
IC50 |
12350.0 |
nM |
10.1128/aac.00803-09 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
MIC |
64.0 |
ug.mL-1 |
10.1016/j.bmc.2014.07.050 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
MIC |
50000.0 |
nM |
10.1128/aac.00803-09 |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Sarcoplasmic/endoplasmic reticulum calcium ATP-ase |
IC50 |
45000.0 |
nM |
10.1021/acs.jmedchem.9b01509 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
1900.0 |
nM |
10.1021/acs.jmedchem.8b00329 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
1480.0 |
nM |
10.6019/CHEMBL3392926 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
6000.0 |
nM |
10.1016/j.bmc.2010.01.068 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
9528.3 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
16944.1 |
nM |
None |
| Plasmodium falciparum (isolate 3D7) |
Calcium-dependent protein kinase 4 |
Ki |
150000.0 |
nM |
10.1021/acs.jmedchem.8b00329 |
| Pneumocystis carinii |
Pneumocystis carinii |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Rattus norvegicus |
Adrenergic receptor alpha-1 |
IC50 |
350.0 |
nM |
10.1021/jm00153a010 |
| Rattus norvegicus |
Adrenergic receptor alpha-1 |
Ki |
29.3 |
nM |
10.1021/jm00081a018 |
| Rattus norvegicus |
Aldose reductase |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Aldose reductase |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Androgen Receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Beta-glucuronidase |
IC50 |
7800.0 |
nM |
10.1016/j.bmcl.2003.11.074 |
| Rattus norvegicus |
Brain |
Fu |
0.0007 |
None |
10.1124/dmd.110.036095 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Dopamine D2 receptor |
Bmax |
207.0 |
fM (mg of protein)-1 |
10.1021/jm00153a010 |
| Rattus norvegicus |
Dopamine D2 receptor |
IC50 |
16.0 |
nM |
10.1021/jm00153a010 |
| Rattus norvegicus |
Dopamine D2 receptor |
Kd |
0.5322 |
nM |
10.1021/jm00153a010 |
| Rattus norvegicus |
Dopamine D2 receptor |
Ki |
2.2 |
nM |
10.1021/jm00081a018 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glycine receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Glycine receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Inositol monophosphatase 1 |
Potency |
1412.5 |
nM |
None |
| Rattus norvegicus |
Insulin receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Liver |
IC50 |
nan |
None |
10.1002/hep.27206 |
| Rattus norvegicus |
Lysozyme C |
IC50 |
9000.0 |
nM |
10.1016/j.bmcl.2003.11.074 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M1 |
Potency |
10000.0 |
nM |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
18105.6 |
nM |
None |
| Rattus norvegicus |
Protein kinase C (PKC) |
IC50 |
30.0 |
ug.mL-1 |
10.1021/np50100a021 |
| Rattus norvegicus |
Protein kinase C (PKC) |
IC50 |
500000.0 |
nM |
10.1016/s0960-894x(99)00375-3 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
0.5 |
mg.kg-1 |
10.1021/jm00081a018 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
0.52 |
mg.kg-1 |
10.1021/jm00125a020 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
1.7 |
mg.kg-1 |
10.1021/jm00081a018 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
3.0 |
mg.kg-1 |
10.1021/jm00153a010 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
6.5 |
mg.kg-1 |
10.1021/jm00153a010 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
6.9 |
mg.kg-1 |
10.1021/jm00153a010 |
| Rattus norvegicus |
Rattus norvegicus |
IC50 |
2700.0 |
nM |
10.1016/j.bmcl.2003.11.074 |
| Rattus norvegicus |
Rattus norvegicus |
IC50 |
6600.0 |
nM |
10.1016/j.bmcl.2003.11.074 |
| Rattus norvegicus |
Rattus norvegicus |
IC50 |
10100.0 |
nM |
10.1021/jm020102v |
| Rattus norvegicus |
Rattus norvegicus |
IC50 |
12800.0 |
nM |
10.1021/jm020102v |
| Rattus norvegicus |
Rattus norvegicus |
IC50 |
14700.0 |
nM |
10.1016/s0960-894x(01)00353-5 |
| Rattus norvegicus |
Rattus norvegicus |
Log 1/ED50 |
2.92 |
None |
10.1021/jm00135a006 |
| Rattus norvegicus |
Rattus norvegicus |
Loss |
1.2 |
% |
10.1021/jm00125a020 |
| Rattus norvegicus |
Rattus norvegicus |
Papp |
3.9 |
None |
10.1021/jm00135a006 |
| Rattus norvegicus |
Serotonin 1 (5-HT1) receptor |
Ki |
1000.0 |
nM |
10.1021/jm00081a018 |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
Ki |
411.0 |
nM |
10.1021/jm00081a018 |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 2 (5-HT2) receptor |
Bmax |
53.43 |
fM (mg of protein)-1 |
10.1021/jm00153a010 |
| Rattus norvegicus |
Serotonin 2 (5-HT2) receptor |
Kd |
1.043 |
nM |
10.1021/jm00153a010 |
| Rattus norvegicus |
Serotonin 2 (5-HT2) receptor |
Ki |
5.2 |
nM |
10.1021/jm00081a018 |
| Rattus norvegicus |
Serum albumin |
Kd |
14000.0 |
nM |
10.1124/dmd.110.036095 |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Voltage-gated N-type calcium channel alpha-1B subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
Potency |
3264.3 |
nM |
None |
| Saccharomyces cerevisiae S288c |
C-8 sterol isomerase |
Ki |
500.0 |
nM |
10.1021/jm049073+ |
| Saccharomyces cerevisiae S288c |
Pleiotropic ABC efflux transporter of multiple drugs |
IC50 |
1400.0 |
nM |
10.1128/aac.00956-08 |
| Saccharomyces cerevisiae S288c |
Pleiotropic ABC efflux transporter of multiple drugs |
INH |
8.3 |
uM |
10.1128/aac.00956-08 |
| Saccharomyces cerevisiae (strain Lalvin EC1118 / Prise de mousse)(Baker's yeast) |
Snq2p |
INH |
6.9 |
uM |
10.1128/aac.00956-08 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
6456.54 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
6460.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
100000.0 |
nM |
10.6019/CHEMBL4651402 |
| Toxoplasma gondii |
Toxoplasma gondii |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trichomonas vaginalis |
Trichomonas vaginalis |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trypanosoma brucei |
Trypanosoma brucei |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trypanosoma brucei rhodesiense |
Trypanosoma brucei rhodesiense |
IC50 |
1230.0 |
nM |
10.6019/CHEMBL3392926 |
| Trypanosoma brucei rhodesiense |
Trypanosoma brucei rhodesiense |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
IC50 |
10130.0 |
nM |
10.6019/CHEMBL3392926 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trypanosoma cruzi |
Trypanothione reductase |
IC50 |
72000.0 |
nM |
10.1021/jm960814j |
| Trypanosoma cruzi |
Trypanothione reductase |
Ki |
23000.0 |
nM |
10.1021/jm960814j |
| None |
ADMET |
Kd |
392.0 |
nM |
10.1124/dmd.110.036095 |
| None |
ADMET |
Log k' |
2.58 |
None |
10.1021/jm00135a006 |
| None |
ADMET |
Log k' |
3.076 |
None |
10.1021/jm00135a006 |
| None |
ADMET |
logP(lung) |
1.33 |
None |
10.1016/j.ejmech.2007.04.002 |
| None |
ADMET |
Papp |
0.5 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
1.0 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
1.1 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
1.3 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
PPB |
99.19 |
% |
10.6019/CHEMBL3301361 |
| None |
ADMET |
PPB |
99.3 |
% |
10.6019/CHEMBL3301361 |
| None |
ADMET |
Ratio |
-16.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
0.9 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
1.9 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
2.6 |
None |
10.1124/dmd.110.036095 |
| None |
ADMET |
Ratio |
53.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
144.0 |
None |
10.1124/dmd.110.034629 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Index Value |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Number of Reports |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Active |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Marginal |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Index Value |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Number of Reports |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx1000865 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1124/dmd.110.035113 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
LDH Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Index Value |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Number of Reports |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LTKB_BD DILI severity score |
2.0 |
None |
10.1016/j.drudis.2011.05.007 |
| None |
Hepatotoxicity |
SGOT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Index Value |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Number of Reports |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Index Value |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Number of Reports |
nan |
None |
10.2174/1570163043334794 |
| None |
Molecular identity unknown |
Fu |
0.0018 |
None |
10.1124/dmd.110.036095 |
| None |
Molecular identity unknown |
Fu |
0.0033 |
None |
10.1124/dmd.110.036095 |
| None |
Neutrophil |
Activity |
0.54 |
nmol |
10.1016/j.bmcl.2006.02.005 |
| None |
Neutrophil |
Activity |
1.23 |
nmol |
10.1016/j.bmcl.2006.02.005 |
| None |
Neutrophil |
Activity |
2.1 |
nmol |
10.1016/j.bmcl.2006.02.005 |
| None |
Neutrophil |
Activity |
3.4 |
nmol |
10.1016/j.bmcl.2006.02.005 |
| None |
Neutrophil |
Activity |
5.48 |
nmol |
10.1016/j.bmcl.2006.02.005 |
| None |
Neutrophil |
Activity |
28.0 |
nmol |
10.1016/j.bmcl.2006.02.005 |
| None |
Neutrophil |
IC50 |
2700.0 |
nM |
10.1016/j.bmcl.2006.02.005 |
| None |
Neutrophil |
IC50 |
6600.0 |
nM |
10.1016/j.bmcl.2006.02.005 |
| None |
Neutrophil |
IC50 |
12700.0 |
nM |
10.1016/j.ejmech.2006.12.009 |
| None |
Neutrophil |
IC50 |
13200.0 |
nM |
10.1016/j.ejmech.2006.12.009 |
| None |
Neutrophil |
Inhibition |
1.7 |
% |
10.1016/j.bmcl.2006.02.005 |
| None |
Neutrophil |
Inhibition |
24.2 |
% |
10.1016/j.bmcl.2006.02.005 |
| None |
Neutrophil |
Inhibition |
27.6 |
% |
10.1016/j.bmcl.2006.02.005 |
| None |
Neutrophil |
Inhibition |
55.4 |
% |
10.1016/j.bmcl.2006.02.005 |
| None |
Neutrophil |
Inhibition |
79.5 |
% |
10.1016/j.bmcl.2006.02.005 |
| None |
Neutrophil |
Inhibition |
83.3 |
% |
10.1016/j.bmcl.2006.02.005 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
2.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
IC50 |
10990.0 |
nM |
10.6019/CHEMBL3392926 |
| None |
NON-PROTEIN TARGET |
IC50 |
11900.0 |
nM |
10.1016/j.bmc.2009.07.054 |
| None |
NON-PROTEIN TARGET |
IC50 |
12200.0 |
nM |
10.1021/np020135d |
| None |
NON-PROTEIN TARGET |
IC50 |
12500.0 |
nM |
10.1016/j.bmc.2009.07.054 |
| None |
NON-PROTEIN TARGET |
IC50 |
13200.0 |
nM |
10.1021/np020135d |
| None |
NON-PROTEIN TARGET |
IC50 |
24540.0 |
nM |
10.6019/CHEMBL3392926 |
| None |
NON-PROTEIN TARGET |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| None |
NON-PROTEIN TARGET |
MIC |
32.0 |
ug.mL-1 |
10.1128/aac.00661-08 |
| None |
NON-PROTEIN TARGET |
MIC |
64.0 |
ug.mL-1 |
10.1128/aac.00661-08 |
| None |
NON-PROTEIN TARGET |
MIC |
1024.0 |
ug.mL-1 |
10.1128/aac.00661-08 |
| None |
NON-PROTEIN TARGET |
Potency |
1.1 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
10.6 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
84.1 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
472.8 |
nM |
None |
| None |
No relevant target |
LogD |
1.775 |
None |
10.1021/jm00135a006 |
| None |
No relevant target |
LogD |
1.96 |
None |
10.1021/jm00135a006 |
| None |
No relevant target |
LogD |
8.1 |
None |
10.1021/jm00135a006 |
| None |
No relevant target |
LogD7.4 |
4.31 |
None |
10.6019/CHEMBL3301361 |
| None |
No relevant target |
LogP |
5.03 |
None |
10.1021/jm0611105 |
| None |
No relevant target |
LogP |
5.03 |
None |
10.1021/jm070524a |
| None |
No relevant target |
Log S |
-4.52 |
None |
10.1016/s0960-894x(00)00172-4 |
| None |
No relevant target |
pKa |
3.9 |
None |
10.1016/j.ejmech.2016.03.045 |
| None |
No relevant target |
pKa |
3.9 |
None |
10.1021/jm00143a016 |
| None |
No relevant target |
pKa |
4.04 |
None |
10.1021/jm020941h |
| None |
No relevant target |
pKa |
7.61 |
None |
10.1021/jm020941h |
| None |
No relevant target |
pKa |
7.81 |
None |
10.1021/jm020941h |
| None |
No relevant target |
pKa |
8.08 |
None |
10.1021/jm070524a |
| None |
No relevant target |
pKa |
8.1 |
None |
10.1021/jm00143a016 |
| None |
No relevant target |
pKa |
8.1 |
None |
10.1021/jm00213a022 |
| None |
No relevant target |
pKa |
8.1 |
None |
10.1021/jm020941h |
| None |
No relevant target |
Rm |
3.55 |
None |
10.1021/jm00213a022 |
| None |
NSC |
Activity |
nan |
None |
10.1016/j.ejmech.2018.03.055 |
| None |
NSC |
Efficacy |
21.0 |
% |
10.1016/j.ejmech.2018.03.055 |
| None |
NSC |
IC50 |
10100.0 |
nM |
10.1016/j.ejmech.2018.03.055 |
| None |
Nucleic Acid |
Kd |
1700.0 |
nM |
10.1021/jm2007694 |
| None |
Nucleic Acid |
Kd |
2000.0 |
nM |
10.1021/jm2007694 |
| None |
Nucleic Acid |
Kd |
2190.0 |
nM |
10.1021/jm2007694 |
| None |
Unchecked |
Activity |
1.69 |
None |
10.1021/jm00135a006 |
| None |
Unchecked |
EC50 |
1340.0 |
nM |
10.1016/j.ejmech.2018.12.033 |
| None |
Unchecked |
EC50 |
1850.0 |
nM |
10.1016/j.ejmech.2018.12.033 |
| None |
Unchecked |
EC50 |
5800.0 |
nM |
10.1016/j.ejmech.2016.03.045 |
| None |
Unchecked |
Efficacy |
85.0 |
% |
10.1016/j.ejmech.2018.03.055 |
| None |
Unchecked |
Hepatotoxicity (acute) |
5.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
4.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
1140.0 |
nM |
10.1016/j.ejmech.2016.03.045 |
| None |
Unchecked |
IC50 |
10200.0 |
nM |
10.1016/j.ejmech.2018.03.055 |
| None |
Unchecked |
IC50 |
12000.0 |
nM |
10.1016/j.bmc.2014.07.050 |
| None |
Unchecked |
IC50 |
45000.0 |
nM |
10.1021/acs.jmedchem.9b01509 |
| None |
Unchecked |
IC50 |
50000.0 |
nM |
10.1016/j.bmcl.2018.05.048 |
| None |
Unchecked |
IC50 |
60070.0 |
nM |
10.1016/j.bmc.2014.07.050 |
| None |
Unchecked |
IC50 |
500000.0 |
nM |
10.1016/s0960-894x(98)00468-5 |
| None |
Unchecked |
IC50 |
nan |
None |
10.1016/j.bmcl.2018.05.048 |
| None |
Unchecked |
IC50 |
nan |
None |
None |
| None |
Unchecked |
INH |
9.8 |
uM |
10.1128/aac.00956-08 |
| None |
Unchecked |
INH |
100.0 |
uM |
10.1016/j.bmc.2014.07.050 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1016/j.bmc.2015.07.007 |
| None |
Unchecked |
Kd |
500.0 |
nM |
10.1021/jm200167g |
| None |
Unchecked |
Kd |
800.0 |
nM |
10.1021/jm200167g |
| None |
Unchecked |
Kd |
1000.0 |
nM |
10.1021/jm200167g |
| None |
Unchecked |
Kd |
2100.0 |
nM |
10.1021/jm200167g |
| None |
Unchecked |
Kd |
5700.0 |
nM |
10.1021/jm200167g |
| None |
Unchecked |
Ki |
24.2 |
nM |
10.1021/jm200167g |
| None |
Unchecked |
Ki |
nan |
None |
None |
| None |
Unchecked |
Log K |
3.91 |
None |
10.1021/jm00135a006 |
| None |
Unchecked |
Potency |
3162.3 |
nM |
None |
| None |
Unchecked |
Potency |
6510.4 |
nM |
None |
| None |
Unchecked |
Potency |
7079.5 |
nM |
None |
| None |
Unchecked |
Potency |
7943.3 |
nM |
None |
| None |
Unchecked |
Potency |
9200.0 |
nM |
None |
| None |
Unchecked |
Potency |
11220.2 |
nM |
None |
| None |
Unchecked |
Potency |
12589.3 |
nM |
None |
| None |
Unchecked |
Potency |
14125.4 |
nM |
None |
| None |
Unchecked |
Potency |
15848.9 |
nM |
None |
| None |
Unchecked |
Potency |
22387.2 |
nM |
None |
| None |
Unchecked |
Potency |
22793.6 |
nM |
None |
| None |
Unchecked |
Potency |
28183.8 |
nM |
None |
| None |
Unchecked |
Potency |
29092.9 |
nM |
None |
| None |
Unchecked |
Potency |
35481.3 |
nM |
None |
| None |
Unchecked |
Potency |
44668.4 |
nM |
None |
| None |
Unchecked |
Ratio Ki |
52.0 |
None |
10.1016/j.bmc.2012.10.038 |